Split History
ETFs Holding SLXP »    SLXP Historical Stock Prices »
Video: What is a Stock Split?

If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Salix Pharmaceuticals is a pharmaceutical company engaged in acquiring, developing and commercializing prescription drugs and medical devices used in the treatment of a range of gastrointestinal diseases, which are those affecting the digestive tract. Co.'s products include among others, XIFAXAN550® (rifaximin) Tablets, indicated for the reduction in risk of overt hepatic encephalopathy recurrence in patients 18 years and older; XIFAXAN (rifaximin) tablets, indicated for the treatment of patients 12 years of age and older with travelers' diarrhea; and APRISO® (mesalamine) extended-release capsules, indicated for the maintenance of remission of ulcerative colitis. According to our SLXP split history records, SLXP has had 1 split.
SLXP split history picture
SLXP (SLXP) has 1 split in our SLXP split history database. The split for SLXP took place on July 13, 2004. This was a 3 for 2 split, meaning for each 2 shares of SLXP owned pre-split, the shareholder now owned 3 shares. For example, a 1000 share position pre-split, became a 1500 share position following the split.

When a company such as SLXP splits its shares, the market capitalization before and after the split takes place remains stable, meaning the shareholder now owns more shares but each are valued at a lower price per share. Often, however, a lower priced stock on a per-share basis can attract a wider range of buyers. If that increased demand causes the share price to appreciate, then the total market capitalization rises post-split. This does not always happen, however, often depending on the underlying fundamentals of the business.

Looking at the SLXP split history from start to finish, an original position size of 1000 shares would have turned into 1500 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into SLXP shares, starting with a $10,000 purchase of SLXP, presented on a split-history-adjusted basis factoring in the complete SLXP split history. SLXP split adjusted history picture

Growth of $10,000.00
Without Dividends Reinvested

Start date: 05/24/2010
End date: 04/01/2015
Start price/share: $35.42
End price/share: $172.81
Dividends collected/share: $0.00
Total return: 387.89%
Average Annual Total Return: 38.58%
Starting investment: $10,000.00
Ending investment: $48,788.26
Years: 4.86
Date Ratio
07/13/20043 for 2
SLXP is categorized under the Healthcare sector; below are some other companies in the same sector that also have a history of stock splits:

SNOA Split History
SNSS Split History
SRDX Split History
SRPT Split History
SRRA Split History
SSH Split History
SSKN Split History
STAA Split History
STE Split History
STEM Split History

Laredo Petroleum, Inc. (LPI)
Global Eagle Entertainment Inc. (ENT)
ToughBuilt Industries, Inc. (TBLT)
Cyclacel Pharmaceuticals, Inc. (CYCC)
Chesapeake Energy Corporation (CHK)
Direxion Daily Gold Miners Index Bull 3X Shares (NUGT)
Direxion Zacks MLP High Income Index Shares (ZMLP)
Direxion Daily Retail Bull 3X Shares (RETL)
Direxion Daily Robotics, Artificial Intelligence & Automation Index Bull 3X Shares (UBOT)
Direxion Daily Junior Gold Miners Index Bull 3X Shares (JNUG)
More latest stock splits »
Latest mega mergers »
Latest stock buybacks »

SLXP Insider Buying

SLXP Split History | www.SplitHistory.com | Copyright © 2013 - 2020, All Rights Reserved

Nothing in www.SplitHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.